Latest total liabilities for AOLS: $590K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest total liabilities for AOLS is $590K as of June 2017. That compares with $690K in the prior-year period — down 14.7% year over year. Investors often review this figure alongside Aeolus Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.
Over the past year, AOLS's total liabilities moved from $690K to $590K — a 14.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Aeolus Pharmaceuticals's operating scale or balance-sheet position.
A total liabilities figure of $590K for AOLS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting AOLS's total liabilities ($590K), review year-over-year change from $690K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.